Associate Professor (Translational Research), PI Hasan Lab ACTREC Tata Memorial Centre Mumbai India. https://xitter.cf/t.co/auOGPDy3KE
Joined August 2018
- Tweets178
- Following181
- Followers313
- Likes315
Syed K. Hasan retweeted
Thankyou @CRI_ACTREC for the continued support, and to my PI @SyedKHasan1 for the constant guidance, encouragement, and belief in my work. Excited for this new chapter with the LOTUS Aspire Fellowship at Japan! 🇮🇳🇯🇵
Congratulations to Ms Neha Gupta, PhD student in @SyedKHasan1 Lab, on being awarded the prestigious LOTUS Fellowship 2026! Neha will undertake one year of research work in Japan. Proud of this achievement @nehagupta_06 @biopatrika @ACTREC_TMC
Syed K. Hasan retweeted
Congratulations to Ms Neha Gupta, PhD student in @SyedKHasan1 Lab, on being awarded the prestigious LOTUS Fellowship 2026! Neha will undertake one year of research work in Japan. Proud of this achievement @nehagupta_06 @biopatrika @ACTREC_TMC
Syed K. Hasan retweeted
#PhDone_and_dusted
Successfully defended my PhD thesis on 24th Aug in hematological oncology. Special thanks to my supervisor @SyedKHasan1 for all his guidance and support to achieve this milestone. Officially signing off as Dr. Dutta😌
Syed K. Hasan retweeted
Anup Jha, Dr. Syed Hasan's lab @ACTREC_TMC has been awarded the prestigious Fulbright Nehru Doctoral Research Fellowship (2026-27) for 9 months in the USA. His research would focus on understanding the mechanisms of therapy resistance in AML! @biopatrika
Syed K. Hasan retweeted
Glad to share my Ph.D work on ATO resistance in APL has published online! We uncover mechanisms to guide better treatment in ATO resistant APL. A big thanks to my Ph.D guide @SyedKHasan1 for his enormous support and trust to achieve this milestone!
link.springer.com/article/10…
Syed K. Hasan retweeted
Cases of Acute Myeloid Leukaemia (AML) - a rare, fast-growing cancer of the blood and bone marrow - are rising in the 30-40 age group. Individuals previously exposed to radiation or chemotherapy may be at higher risk. A simple blood test can help detect AML early.
Syed K. Hasan retweeted
Historical
#Personalized_Gene_Editing to Treat an Inborn Error of Metabolism
Disease causing DNA letter was corrected to a healthy version by #Adenine_Base_Editor (ABE)
Great work @kiranmusunuru
ABE was originally invented by @NicoleGaudelli @davidrliu
nejm.org/doi/full/10.1056/NE…
Syed K. Hasan retweeted
2012 a friend said- “Science Fiction”
2015 we dared to dream
Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial
We report 92% ORR 3 dose levels
@Nature @BloodCancerJnl @purwarrahul2 @ActImmuno @CTCTC_tmc @NiraliShahMD @TataMemorial @DrSwamiPeds @AlkaDwivedi06 rdcu.be/ei7xh
Sunday reading with your coffee! thehindu.com/sci-tech/rare-b… @ACTREC_TMC @CRI_ACTREC @SocietyofHemOnc @EHA_Hematology @BloodAdvances
Syed K. Hasan retweeted
Full version article out now!!
Congratulations @SyedKHasan1
Lab and @maityakash48
@biopatrika @ACTREC_TMC
@BloodAdvances
ashpublications.org/bloodadv…
Syed K. Hasan retweeted
Led by Drs. Jayastu Senapati (@jayastuMD) and Naval Daver (@Daver_Leukemia), this retrospective analysis in @Haematologica included patients with newly diagnosed #MyelodysplasticSyndrome and #AML with TP53 mutations. 🩺
💡 Learn more: bit.ly/4gjHZYr
Syed K. Hasan retweeted
I'm thrilled to announce that my paper in redox biology is finally out! This milestone marks my first solo corresponding author publication, a significant achievement i'm proud to share. Seeing the final product is surreal, and I'm grateful to share this moment with you. (1/6)
Syed K. Hasan retweeted
Huge congratulations to my amazing student-friends for their outstanding work! CRISPR-Cas system is set to revolutionize cancer diagnostics. Proud of this brilliant team! @ACTREC_TMC @AML_Hub @BloodAdvances @BloodJournal @CRI_ACTREC @TataMemorial
Syed K. Hasan retweeted
(2) We developed CRISPR-Cas12 assay to detect PML-RARA isoforms on a lateral flow strip with ultimate goal of achieving equipment-free acute promyelocytic leukemia diagnosis suitable for OPD settings.
Article: shorturl.at/Ymz93
Huge congratulations to my amazing student-friends for their outstanding work! CRISPR-Cas system is set to revolutionize cancer diagnostics. Proud of this brilliant team! @ACTREC_TMC @AML_Hub @BloodAdvances @BloodJournal @CRI_ACTREC @TataMemorial
(2) We developed CRISPR-Cas12 assay to detect PML-RARA isoforms on a lateral flow strip with ultimate goal of achieving equipment-free acute promyelocytic leukemia diagnosis suitable for OPD settings.
Article: shorturl.at/Ymz93
Huge thanks to @AurigeneDiscov and @MuraliRamachan5
Many congratulations and very proud of you @Gaur_tarang on winning soho young investigator fellowship at prestigious @SocietyofHemOnc excellent work which is going soon in clinics. hope you will return to contribute to indian science again. @CRI_ACTREC
Many congratulations and very proud of you @Gaur_tarang on winning soho young investigator fellowship at prestigious @SocietyofHemOnc excellent work which is going soon in clinics. hope you will return to contribute to indian science again. @CRI_ACTREC
This is an amazing piece of work in a very prestigious journal. Many congratulations to all of you
Congratulations to the brilliant PhD student, @MadhuraKetkar for this excellent study identifying molecular switch for TIS reversal in GBM. Paper's now online @NeuroOnc. Thank you co-authors, @DBTIndia, @serbonline, @ACTREC_TMC, @CRI_ACTREC for support
academic.oup.com/neuro-oncol…
Syed K. Hasan retweeted
Presenting #poster at #EHA2024 and receiving prestigious #travel_grant_award is one of the best opportunities in my Ph.D tenure. A big thanks to my Ph.D guide @SyedKHasan1 for all his support, help, and trust in me to achieve it. – at Community of Madrid, Spain
